Skip to main content
Livermore
Livermore
ZHEN

Green Alpha Advisors, LLC

SEC CIK
0001439207
Latest filing
Aug 11, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Green Alpha Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
13,886
Value
$235.0K
% of portfolio
0.2%
Quarters held
19
Since Q1 2021
Holdings of NTLA by Green Alpha Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,886$235.0K0.2%−281−2.0%ReducedHolders
Q1 202614,167$181.6K0.2%−2,526−15.1%ReducedHolders
Q4 202516,693$150.1K0.1%+16,693NewHolders
Q3 20250$00.0%−11,007−100.0%Sold outHolders
Q2 202511,007$103.2K0.1%−1,461−11.7%ReducedHolders
Q1 202512,468$88.6K0.1%+669+5.7%AddedHolders
Q4 202411,799$137.6K0.1%+11,799NewHolders
Q2 20240$00.0%−7,964−100.0%Sold outHolders
Q1 20247,964$219.1K0.2%−2,139−21.2%ReducedHolders
Q4 202310,103$308.0K0.2%−4,674−31.6%ReducedHolders
Q3 202314,777$467.2K0.4%−314−2.1%ReducedHolders
Q2 202315,091$615.4K0.4%+1,187+8.5%AddedHolders
Q1 202313,904$518.2K0.4%−1,467−9.5%ReducedHolders
Q4 202215,371$536.0K0.4%+813+5.6%AddedHolders
Q3 202214,558$815.0K0.7%−67,941−82.4%ReducedHolders
Q2 202282,499$4.27M1.0%+71,748+667.4%AddedHolders
Q1 202210,751$781.0K0.5%+1,617+17.7%AddedHolders
Q4 20219,134$1.08M0.7%+248+2.8%AddedHolders
Q3 20218,886$1.19M0.8%−370−4.0%ReducedHolders
Q2 20219,256$1.50M1.0%−738−7.4%ReducedHolders
Q1 20219,994$802.0K0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.